Literature DB >> 8175696

Precise identification of the regulatory F-actin- and calmodulin-binding sequences in the 10-kDa carboxyl-terminal domain of caldesmon.

M Mezgueldi1, J Derancourt, B Calas, R Kassab, A Fattoum.   

Abstract

The precise location of the regulatory F-actin- and calmodulin-binding sites in the COOH-terminal sequence Trp659-Pro756 of gizzard caldesmon was investigated by subjecting the corresponding 10-kDa CNBr fragment, characterized earlier (Bartegi, A., Fattoum, A., Derancourt, J., and Kassab, R. (1990) J. Biol. Chem. 265, 15231-15238), to limited chymotryptic reactions conducted in the absence and presence of F-actin-tropomyosin. As a result, the F-actin-binding and actomyosin ATPase inhibitory activity was separated from the regulatory Ca(2+)-calmodulin-binding site. Seven chymotryptic peptides accounting for the entire primary structure of the CB10 fragment were isolated, and their complete amino acid sequences were established by combining NH2-terminal sequencing, mass spectrometry, and gel electrophoresis. Reversed-phase high performance liquid chromatography analyses of the binding of F-actin to these peptides revealed the 30-residue sequence Leu693-Trp722 as the unique crucial stretch for actin interaction and ATPase inhibition. This segment was also specifically protected by F-actin against proteolytic degradation. We further determined the functional properties of three synthetic peptides which successively cover the sequences Asn675-Lys695, Leu693-Trp722, and Arg711-Lys729. The first peptide segment specifically bound Ca(2+)-calmodulin as assessed by affinity chromatography and spectrofluorometry and should contain a potent novel calmodulin-binding subsite. The second immediately adjacent peptide inhibited the actomyosin ATPase in a tropomyosin-sensitive manner, as expected. In contrast, the third peptide displayed no detectable function. The results indicate that the overall sequence Asn675-Trp722 represents the essential regulatory unit of the COOH-terminal 10-kDa domain of caldesmon.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175696

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Interaction of proteolytic fragments of calmodulin with caldesmon and calponin.

Authors:  M V Medvedeva; E A Kolobova; P Wang; N B Gusev
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

2.  Affinity and structure of complexes of tropomyosin and caldesmon domains.

Authors:  E J Hnath; C L Wang; P A Huber; S B Marston; G N Phillips
Journal:  Biophys J       Date:  1996-10       Impact factor: 4.033

3.  Mapping of contact sites in the caldesmon-calmodulin complex.

Authors:  M V Medvedeva; E A Kolobova; P A Huber; I D Fraser; S B Marston; N B Gusev
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

4.  Utilization of troponin C as a model calcium-binding protein for mapping of the calmodulin-binding sites of caldesmon.

Authors:  A A Polyakov; N B Gusev
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

5.  Phosphatidylserine liposomes can be tethered by caldesmon to actin filaments.

Authors:  R Makuch; A Zasada; K Mabuchi; K Krauze; C L Wang; R Dabrowska
Journal:  Biophys J       Date:  1997-09       Impact factor: 4.033

6.  Characterization of the functional properties of smooth muscle caldesmon domain 4a: evidence for an independent inhibitory actin-tropomyosin binding domain.

Authors:  M El-Mezgueldi; O Copeland; I D Fraser; S B Marston; P A Huber
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

7.  Alignment of caldesmon on the actin-tropomyosin filaments.

Authors:  T S Tsuruda; M H Watson; D B Foster; J J Lin; A S Mak
Journal:  Biochem J       Date:  1995-08-01       Impact factor: 3.857

8.  Location of smooth-muscle myosin and tropomyosin binding sites in the C-terminal 288 residues of human caldesmon.

Authors:  P A Huber; I D Fraser; S B Marston
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

9.  Caldesmon inhibits nonmuscle cell contractility and interferes with the formation of focal adhesions.

Authors:  D M Helfman; E T Levy; C Berthier; M Shtutman; D Riveline; I Grosheva; A Lachish-Zalait; M Elbaum; A D Bershadsky
Journal:  Mol Biol Cell       Date:  1999-10       Impact factor: 4.138

10.  Multiple-sited interaction of caldesmon with Ca(2+)-calmodulin.

Authors:  P A Huber; M El-Mezgueldi; Z Grabarek; D A Slatter; B A Levine; S B Marston
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.